Inhibitory effect of somatostatin on dibutyryl cyclic AMP-induced insulin and growth hormone release in human subjects
- 1 March 1976
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 25 (3) , 321-328
- https://doi.org/10.1016/0026-0495(76)90090-1
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patientsMetabolism, 1975
- Effect of Somatostatin on Plasma Glucose and Insulin Responses to Glucagon and Tolbutamide in ManJournal of Clinical Endocrinology & Metabolism, 1974
- Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patientsMetabolism, 1974
- Direct inhibition of insulin secretion by synthetic somatostatinBiochemical and Biophysical Research Communications, 1974
- Somatostatin: Hypothalamic Inhibitor of the Endocrine PancreasScience, 1974
- EFFECTS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE ON CIRCULATING GLUCAGON, INSULIN, AND GROWTH HORMONE IN NORMAL, DIABETIC, ACROMEGALIC, AND HYPOPITUITARY PATIENTSThe Lancet, 1974
- INHIBITION OF INSULIN SECRETION BY SOMATOSTATINThe Lancet, 1973
- INHIBITION OF GROWTH HORMONE RELEASE IN HUMANS BY SOMATOSTATIN.Journal of Clinical Endocrinology & Metabolism, 1973
- ACTION OF GROWTH-HORMONE-RELEASE INHIBITORY HORMONE IN HEALTHY MEN AND IN ACROMEGALYThe Lancet, 1973
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973